Furthermore, we analyzed CYLD expression levels in the GEPIA database, and the results revealed that CYLD was a tumor suppressor in ovarian cancer, and CYLD expression levels were reduced in clinical advanced stages of cancer patients (Fig. 1D). The gene discussed is CYLD; the disease is neoplasm.